| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Motus GI Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.039 |
| 52 Week High | US$10.05 |
| 52 Week Low | US$0.015 |
| Beta | 1.81 |
| 11 Month Change | 24.68% |
| 3 Month Change | -12.44% |
| 1 Year Change | -99.43% |
| 33 Year Change | -99.98% |
| 5 Year Change | -99.99% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Motus GI regains compliance with minimum bid price requirement
Aug 11Motus GI Holdings announces 1-for-20 reverse stock split to satisfy Nasdaq's minimum bid requirement
Jul 25Motus GI starts enrollment in Pure-Vu System EU study
Jun 16Motus GI shares rocket 55% on FDA 510(k) clearance of Pure-Vu System
Apr 30Here's Why Motus GI Holdings (NASDAQ:MOTS) Can Manage Its Debt Despite Losing Money
Mar 02
Shareholder Returns
| MOTS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 1.5% | -2.5% | -0.7% |
| 1Y | -99.4% | 19.8% | 32.5% |
Return vs Industry: MOTS underperformed the US Medical Equipment industry which returned 19.8% over the past year.
Return vs Market: MOTS underperformed the US Market which returned 32.5% over the past year.
Price Volatility
| MOTS volatility | |
|---|---|
| MOTS Average Weekly Movement | 38.2% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: MOTS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MOTS's weekly volatility (38%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 15 | n/a | www.motusgi.com |
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
Motus GI Holdings, Inc. Fundamentals Summary
| MOTS fundamental statistics | |
|---|---|
| Market cap | US$251.68k |
| Earnings (TTM) | -US$16.10m |
| Revenue (TTM) | US$327.00k |
0.9x
P/S Ratio0.0x
P/E RatioIs MOTS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MOTS income statement (TTM) | |
|---|---|
| Revenue | US$327.00k |
| Cost of Revenue | US$407.00k |
| Gross Profit | -US$80.00k |
| Other Expenses | US$16.02m |
| Earnings | -US$16.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.24 |
| Gross Margin | -24.46% |
| Net Profit Margin | -4,924.16% |
| Debt/Equity Ratio | 75.0% |
How did MOTS perform over the long term?
See historical performance and comparison